Enhanced immune response to DNA-based HPV16L1 vaccination by costimulatory molecule B7-2
- 1 June 2003
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 59 (1) , 61-65
- https://doi.org/10.1016/s0166-3542(03)00031-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and TransplantationAnnual Review of Immunology, 2001
- Functional Equivalency of B7-1 and B7-2 for Costimulating Plasmid DNA Vaccine-Elicited CTL ResponsesThe Journal of Immunology, 2000
- B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccinationEuropean Journal of Immunology, 2000
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genesNature Biotechnology, 1997
- Immunoglobulin G Responses Against Human Papillomavirus Type 16 Virus-Like Particles in a Prospective Nonintervention Cohort Study of Women With Cervical Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 1997
- HIV‐1‐specific cell‐mediated immunity is enhanced by co‐inoculation of TCA3 expression plasmid with DNA vaccineImmunology, 1997
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Genetic immunization is a simple method for eliciting an immune responseNature, 1992
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990